everolimus for non-functional neuroendocrine tumours
Published 8 years ago • 224 plays • Length 3:14Download video MP4
Download video MP3
Similar videos
-
5:52
everolimus in pancreatic neuroendocrine tumors and carcinoid tumors
-
7:19
radiant-4: results of international trial show promise in the treatment of neuroendocrine tumours
-
3:35
everolimus in pancreatic neuroendocrine tumors
-
0:47
significance of radiant-4 study for advanced nonfunctional nets of lung or gastrointestinal origin
-
13:21
debate: does everolimus have a role in carcinoid tumors? - no
-
22:53
functional v. nonfunctional net symptoms, heloisa soares, md, phd
-
2:14
dr. james c. yao on everolimus in pancreatic neuroendocrine tumors
-
7:29
ecc 2015: radiant-4 trial showed promise in the treatment of neuroendocrine tumours
-
5:43
targeted therapies for the treatment of nets
-
2:01
dr. james yao on everolimus in advanced pancreatic neuroendocrine tumors
-
3:33
radiant-3 trial: everolimus in pancreatic neuroendocrine tumors
-
4:38
everolimus and sunitinib in pancreatic neuroendocrine tumors
-
3:39
targeted therapies in neuroendocrine tumors
-
8:00
everolimus octreotide lar in patients with advanced lung nets: analysis from radiant-2
-
4:20
phase ii study of adjuvant everolimus on pancreatic neuroendocrine tumors of the liver
-
6:25
targeted treatment options for patients with neuroendocrine tumors
-
7:48
effect of everolimus on markers of angiogenesis in patients with advanced pnet
-
8:51
does treatment with everolimus octreotide lar affect 5-hiaa levels in patients with advanced nets?
-
8:02
symptom management in functional neuroendocrine tumors